Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SCIEX develops and markets advanced mass spectrometry and capillary electrophoresis instruments as well as integrated software solutions. Their technologies are widely adopted in life sciences research—including proteomics, metabolomics, lipidomics—clinical diagnostics, pharmaceutical development, environmental testing and food safety. The company has a long history of innovation such as the first commercial triple quadrupole mass spectrometer. It does not develop drugs or biologics but enables critical discoveries across biomedical fields.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SCIEX.